NEWS: We’ve entered into a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals to develop next-generation therapies for #psychiatric disorders. Learn more: https://bit.ly/4ala9OZ [Video description: On-screen text reads, “Neuroscience News.”]
Neuroscience
Pharmaceutical Manufacturing
AbbVie's perseverance in neuroscience is grounded in innovative research and our commitment to preserve personhood.
About us
Follow AbbVie’s Neuroscience page for news and updates about our commitment to help those living with and affected by the realities of neurological and psychiatric disorders such as Alzheimer’s disease, bipolar disorder and depression, major depressive disorder, migraine, Parkinson’s disease, spinal cord injuries, post-stroke spasticity, schizophrenia, and stroke.
- Website
-
https://www.abbvie.com/our-science/therapeutic-focus-areas/neuroscience.html
External link for Neuroscience
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
Updates
-
Understanding the complexities surrounding mental illnesses – and how we can treat them – has never been more important. Learn how our #scientists are working to find answers to some of the most complex questions in psychiatry and addressing the stigma around mental illness: https://bit.ly/3ydEK3G #MentalHealthAwarenessMonth
-
Read this first-person account of the nighttime symptoms of #ParkinsonsDisease (PD) by Larry Gifford, a person living with PD and president of PD Avengers, an organization we’re proud to partner with on the #SparktheNight campaign.
I wrote a little something for NeurologyLive about night time symptoms of Parkinson's disease. https://lnkd.in/gHD24bke
-
NEWS: Today at #AANAM, we announced late-breaking interim analysis from two lead-in Phase 3 clinical trials for the preventive treatment of #migraine. Read the findings: https://bit.ly/3Uiksic [Video description: On-screen text reads, “Neuroscience News.”]
-
An estimated 39 million people worldwide live with #bipolar disorder. That’s why our scientists are working to find answers to the most complex questions and solutions to the most difficult challenges in #psychiatry. Explore: https://bit.ly/43D5uGm #WorldBipolarDay [Video description: Niki Patel, VP, US Medical Affairs at AbbVie, says: “We’re driven by the pursuit of unraveling the complexities of the human mind which fuels the synergy of rigorous research and compassionate care to advancing the frontiers of mental well-being.”]
-
JUST IN: The Lancet Neurology published results from our Phase 3 trial in episodic #migraine. Read the findings: https://bit.ly/3OIpWQ3 [Video description: On-screen text reads, “Neuroscience News.”]
-
A new survey from the EMHA- European Migraine and Headache Alliance found people living with #migraine often experience stigma due to lack of understanding of the disease – which can negatively impact one’s career and daily life. Read more: https://bit.ly/3uAjzHr [Video description: 79% of people living with migraine have experienced difficulties completing tasks at work or their careers have been negatively affected due to this disease.]
-
Patients with #ParkinsonsDisease can experience symptoms such as tremor, muscle rigidity, slowness of movement and difficulty with balance. Our goal is to advance #research that helps them regain and maintain their independence. Explore our #neuroscience efforts: https://bit.ly/3Su8yPW [Video description: On-screen text reads, “For people living with Parkinson’s Disease, symptoms can continue all day long.” Featuring icons depicting a clock, the sun and the moon.]
-
People living with #ParkinsonsDisease can have difficulty performing daily activities as the disease progresses. Our goal is to ensure patients are equipped to manage their disease in partnership with their doctor. Explore our commitment to the #neuroscience community: https://bit.ly/3udCp7g [Video description: On-screen text outlines key motor and non-motor symptoms of Parkinson’s disease (PD), followed by an outline of the terms “on time” and “off time” related to PD symptoms.]
-
#ParkinsonsDisease can take a significant toll on patients and their caregivers. That’s why we’re working to make a real difference for people with PD and other #neurological conditions – through research and partnerships with organizations like Parkinson's Europe. Explore: https://bit.ly/3vJL69z [Video description: Josefa Domingos, President at Parkinson’s Europe, says: “As Parkinson’s progresses, it can take a significant physical and emotional toll not only on the person but also on their family and care partners, who often play a critical role in their daily lives. It is vital that the Parkinson’s community have more options that can help them manage their symptoms.”]